Drug Topics

OCTOBER 4, 2022

Does the severe flu season in the southern hemisphere hint at a tough season for the north?

567

567

Drug Topics

SEPTEMBER 7, 2022

Keep your pharmacy vaccine-ready for your youngest patients with the most current influenza vaccination information from the American Academy of Pediatrics.

Vaccines 504

Vaccines 504

Drug Topics

NOVEMBER 25, 2022

Take a look back at our most popular health system coverage for 2022.

282

282

Drug Topics

NOVEMBER 29, 2023

This season marks the fourth to be classified as high severity since the 2009 influenza A(H1N1) pandemic.

469

469

PharmaVoice

SEPTEMBER 6, 2022

From standout executives to R&D pioneers — this year’s class of honorees is defining the next era of leadership.

344

344

PharmaVoice

NOVEMBER 21, 2022

Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound.

264

264

Drug Topics

DECEMBER 29, 2022

Take a look back at our most popular dermatology coverage for 2022.

247

247

Drug Topics

DECEMBER 23, 2022

Take a look back at our most popular conference coverage for 2022.

247

247

Drug Topics

DECEMBER 22, 2022

Take a look back at our most popular biosimilars coverage for 2022.

247

247

Drug Topics

DECEMBER 20, 2022

Take a look back at our most popular respiratory coverage for 2022.

247

247

Drug Topics

JANUARY 4, 2023

Research on last season’s influenza vaccine efficacy bodes well for patients who have gotten their flu shot this season.

Vaccines 468

Vaccines 468

Drug Topics

DECEMBER 28, 2022

Take a look back at our most popular Total Pharmacy coverage for 2022.

247

247

Drug Topics

DECEMBER 28, 2022

Take a look back at our most popular pain management coverage for 2022.

247

247

Drug Topics

DECEMBER 26, 2022

Take a look back at our most popular podcast episodes and videos for 2022.

247

247

Drug Topics

DECEMBER 21, 2022

Take a look back at our most popular Total Pharmacy business strategy coverage for 2022.

247

247

PhRMA

JANUARY 23, 2023

2022 marked another year of significant progress by biopharmaceutical research companies conducting lifesaving research and development for innovative medicines with a total of 45 new medicine approvals by the U.S. Food and Drug Administration (FDA).

FDA 278

FDA 278

Drug Topics

APRIL 30, 2024

Researchers addressed the wage gaps in specific pharmacy settings in relation to big chain retail pharmacy mergers.

361

361

Drug Topics

OCTOBER 3, 2022

The winner was announced during the first General Session of the 2022 NCPA Annual Convention.

247

247

Drug Topics

OCTOBER 2, 2022

Jordan Cardinal, EM/CC PharmD, a Medical Science Liaison in Integrated Diagnostic Solutions at BD, joins Drug Topics® to discuss the current outlook on the upcoming 2022-2023 flu season, and how the prevalence of the BA.5 5 variant of the SARS-CoV-2 virus might affect the health care outlook over the coming months.

247

247

Drug Topics

MAY 27, 2024

To assess the extent of FTC regulation, researchers collected data from the group’s merger and enforcement actions in a 22-year span.

282

282

Drug Topics

DECEMBER 12, 2022

Investigators set out to evaluate how medication access for certain rheumatic conditions has changed since June 2022.

502

502

Drug Topics

JANUARY 3, 2023

The CDC has reported an increase in drug overdose deaths from 2019 to 2022 in adolescents aged 10 to 19 years.

504

504

PharmaVoice

SEPTEMBER 16, 2022

Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.

246

246

Drug Topics

DECEMBER 30, 2022

Take a look back at our most popular news from December 2022.

468

468

Drug Topics

NOVEMBER 3, 2022

Independent pharmacists stand to gain—or lose—depending on what happens at the polls in November 2022.

469

469

Drug Topics

SEPTEMBER 1, 2022

This recall of propofol because of particulates seen in vials follows a previous one in July 2022.

466

466

Drug Topics

OCTOBER 22, 2022

Results of multiple studies were presented at IDWeek 2022.

Vaccines 449

Vaccines 449

Drug Topics

AUGUST 25, 2023

A 2022 survey conducted by the National Community Pharmacists Association reported that more than 70% of pharmacies were struggling to fill staff positions.

Patient Care 469

Patient Care 469

Drug Topics

JUNE 7, 2023

The median annual cost for new oncology medicines launched in 2022 was $260,000, up from $63,534 10 years ago, an IQVIA report finds.

464

464

Drug Topics

AUGUST 11, 2023

HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.

FDA 468

FDA 468

PhRMA

NOVEMBER 10, 2022

The Working for Cures Employee Champion Awards celebrate the real people in our industry who go above and beyond to advance science and support the work our industry does for patients.

264

264

Drug Topics

DECEMBER 14, 2022

In partnership with LexisNexis Risk Solutions, Drug Topics® asked pharmacists about community outreach, COVID-19 and influenza boosters, and mail order pharmacy trends.

Mail-Order Pharmacies 247

Mail-Order Pharmacies 247

PharmaVoice

NOVEMBER 30, 2022

Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.

242

242

Drug Topics

AUGUST 3, 2023

Although wastewater data and COVID case/hospitalization rates no longer accurately reflect each other, researchers suggest wastewater surveillance may be the best metric for monitoring the amount of circulating virus.

Hospitals 247

Hospitals 247

Drug Topics

MAY 11, 2023

Using a national database, data on medication purchases was collected, along with factors that may have influenced expenditures, such as new therapy availability, patent expirations, policy changes, and legislation.

247

247

PharmaVoice

JANUARY 19, 2023

agency’s lower number of novel drug approvals followed several controversies surrounding a 2021 Alzheimer’s approval.

246

246

Drug Topics

MARCH 28, 2024

Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.

FDA 388

FDA 388